Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (192${count})

  • Research Grant, 2022
    Creation and Testing of a Combined Cognitive Score in Parkinson Disease

    Study Rationale: Many different tests of memory and thinking are given to people with Parkinson’s disease (PD), but it is not clear how to use or combine these test scores to best detect early...

  • Research Grant, 2014
    Clinical and Neuroimaging Predictors of Cognitive Decline in Parkinson’s Disease

    Objective/Rationale:
    Parkinson’s disease (PD) dementia is often preceded by a phase of mild cognitive impairment (PD-MCI), for which diagnostic criteria have been recently proposed. However, there...

  • Defining Cognitive Phenotypes of Parkinson’s Disease, 2011
    Predicting Cognitive Profiles in Parkinson's Disease: A Multimodal Approach

    Objective/Rationale:
    Our proposal aims to determine the optimum combination of techniques to detect rate of cognitive decline in people with newly diagnosed Parkinson’s disease (PD). We will apply...

  • Cognition Biomarkers, 2013
    Validation of Novel and Traditional Quantitative EEG Biomarkers

    Objective/Rationale:
    Cognitive problems commonly add to the disability of the motor symptoms of Parkinson’s disease (PD), but there are no highly effective treatments for cognitive dysfunction in PD...

  • Diversity, Equity and Inclusivity in Parkinson's research, 2022
    Multiculturalism, Reported Cognitive Complaints and Predictors of Cognitive Decline Following Deep Brain Stimulation

    Study Rationale: Cognitive decline is common in people with Parkinson’s disease (PD), and changes in thinking and performance on objective cognitive tests reported by individuals and their family are...

  • Repositioning Drugs for PD, 2012
    Atomoxetine for Cognitive Impairment in Parkinson’s Disease

    Objective/Rationale:
    Parkinson’s disease (PD) causes well known motor symptoms of tremor, slowness and stiffness, but also leads to cognitive impairment. Research has shown that early loss of cells in...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.